Clinical Trial

Off-Label Treatment With Immune Checkpoint Inhibitor Blockade

Name: Off-Label Treatment With Immune Checkpoint Inhibitor Blockade — clinical trial record (NCT07754292)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This is a phase II therapeutic interventional clinical trial that will evaluate the efficacy, safety, and outcomes of off-label immune checkpoint blockade use across malignancies.

Trial Details

NCT Number	NCT07754292
Lead Sponsor	Medical College of Wisconsin
Conditions	Malignancy
Enrollment	231 participants
Start Date	2026-11-01
Primary Completion	2032-11-01 (estimated)
Study Completion	2036-11-01 (estimated)
Updated on ClinicalTrials.gov	2026-08-10